Dornfeld KJ - Search Results

1

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.

Hamstra DA, Lee KC, Tychewicz JM, Schepkin VD, Moffat BA, Chen M, Dornfeld KJ, Lawrence TS, Chenevert TL, Ross BD, Gelovani JT, Rehemtulla A. Hamstra DA, et al. Among authors: dornfeld kj. Mol Ther. 2004 Nov;10(5):916-28. doi: 10.1016/j.ymthe.2004.07.022. Mol Ther. 2004. PMID: 15509509 Free article.

2

Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme/prodrug therapy.

Rehemtulla A, Hamstra DA, Kievit E, Davis MA, Ng EY, Dornfeld K, Lawrence TS. Rehemtulla A, et al. Anticancer Res. 2004 May-Jun;24(3a):1393-9. Anticancer Res. 2004. PMID: 15274300 Free article.

3

The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.

Nyati MK, Symon Z, Kievit E, Dornfeld KJ, Rynkiewicz SD, Ross BD, Rehemtulla A, Lawrence TS. Nyati MK, et al. Among authors: dornfeld kj. Gene Ther. 2002 Jul;9(13):844-9. doi: 10.1038/sj.gt.3301706. Gene Ther. 2002. PMID: 12080378

4

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.

Lee KC, Hamstra DA, Bullarayasamudram S, Bhojani MS, Moffat BA, Dornfeld KJ, Ross BD, Rehemtulla A. Lee KC, et al. Among authors: dornfeld kj. Gene Ther. 2006 Jan;13(2):127-37. doi: 10.1038/sj.gt.3302631. Gene Ther. 2006. PMID: 16163381

5

A predisposition supposition for glioma.

Dornfeld KJ, Lawrence TS. Dornfeld KJ, et al. J Natl Cancer Inst. 2001 Oct 17;93(20):1512-3. doi: 10.1093/jnci/93.20.1512. J Natl Cancer Inst. 2001. PMID: 11604467 No abstract available.

6

Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-D-glucose correlates with increased 18F-FDG uptake as determined by PET imaging.

Simons AL, Fath MA, Mattson DM, Smith BJ, Walsh SA, Graham MM, Hichwa RD, Buatti JM, Dornfeld K, Spitz DR. Simons AL, et al. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1222-30. doi: 10.1016/j.ijrobp.2007.07.2343. Int J Radiat Oncol Biol Phys. 2007. PMID: 17967311 Free PMC article.

7

Ex vivo gene therapy for skeletal regeneration in cranial defects compromised by postoperative radiotherapy.

Nussenbaum B, Rutherford RB, Teknos TN, Dornfeld KJ, Krebsbach PH. Nussenbaum B, et al. Among authors: dornfeld kj. Hum Gene Ther. 2003 Jul 20;14(11):1107-15. doi: 10.1089/104303403322124819. Hum Gene Ther. 2003. PMID: 12885349 Free article.

8

Azidothymidine enhances fluorodeoxyuridine-mediated radiosensitization.

Chen CM, Johnson M, Smith BJ, Dornfeld K. Chen CM, et al. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):905-13. doi: 10.1016/j.ijrobp.2009.09.016. Int J Radiat Oncol Biol Phys. 2010. PMID: 20159365 Free PMC article.

9

Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?

Yao M, Hoffman HT, Chang K, Funk GF, Smith RB, Tan H, Clamon GH, Dornfeld K, Buatti JM. Yao M, et al. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):707-13. doi: 10.1016/j.ijrobp.2006.12.065. Epub 2007 Mar 26. Int J Radiat Oncol Biol Phys. 2007. PMID: 17379453

10

Yao M, Karnell LH, Funk GF, Lu H, Dornfeld K, Buatti JM. Yao M, et al. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1354-60. doi: 10.1016/j.ijrobp.2007.05.003. Epub 2007 Aug 8. Int J Radiat Oncol Biol Phys. 2007. PMID: 17689885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters